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mtDNA Deletions in Aged Human Muscle, by Bua
et al. (p. 469)
As people age, they lose lean muscle mass, primarily
through muscle-ﬁber atrophy and a decrease in the num-
ber of muscle ﬁbers. This loss, or sarcopenia, is usually
accompanied by abnormalities in the electron-transport
system (ETS). mtDNA deletions also accumulate with age,
and previous work has demonstrated that cells with high
levels of mtDNA deletions have abnormal ETS activity. It
remained uncertain whether it is the abundance of mtDNA
deletions that eventually leads to the loss of muscle mass.
This cannot be determined by examining the whole tissue,
because the accumulation of mtDNA-deletion species and
ETS abnormalities occur in a mosaic fashion throughout
the muscle. Here, Bua et al. closely examined the mtDNA
and the ETS function in serial sections along the length
of muscle ﬁbers from individuals of various ages. They
show that, with age, the number and length of regions
with ETS abnormalities increase. Within these regions, the
intracellular level of mtDNA with deletions accounted for
190% of the total mtDNA. Fibers with normal ETS activity
had only wild-type mtDNA. Various mtDNA deletions
were identiﬁed, but each region of ETS dysfunction was
clonal, harboring the same deletion. Along the borders of
these regions, there were transitional areas where the lev-
els of the mtDNA with deletions declined and ETS activity
was normal. This suggests that it is the accumulation of
the mtDNA with deletions that causes the ETS abnormal-
ities and the eventual ﬁber loss.
Fast Computing of Association Signiﬁcance, by
Kimmel and Shamir (p. 481)
A common problem faced by all researchers doing asso-
ciation studies is how to properly correct for multiple test-
ing. As technology makes it ever more possible to type
thousands of markers in thousands of samples, new meth-
odology is necessary to properly measure the observed
effects. It is known that a Bonferroni correction is too
conservative, and this overcorrection becomes even more
pronounced as the number of SNPs increases. Permutation
tests are traditionally used to measure the exact amount
of signiﬁcance of an association, but permutations require
a large number of operations, and the time for calculations
can be restrictive when evaluating a large number ofmark-
ers. This time burden is also limiting when the tests are
used to measure the signiﬁcance of the interactions among
multiple loci. Kimmel and Shamir developed a new meth-
od, Rapid Association Test (RAT), that signiﬁcantly de-
creases the time needed to evaluate signiﬁcance by incor-
porating importance sampling and linkage-disequilibrium
decay. This method has a great advantage over regular
permutation tests when a P value is low and several per-
mutations are necessary to evaluate an association. When
RAT was compared with permutation tests in simulations
and on HapMap data, RAT was 3–5 orders of magnitude
faster.
X-Inactivation Patterns, by Amos-Landgraf et al.
(p. 493)
During the development of female mammals, one X chro-
mosome is inactivated so that, similar to the situation in
males, only one copy of most X-chromosome genes is
expressed. In females with two normal copies of X, it is
thought that inactivation takes place randomly, so that
there is an approximately equal number of cells expressing
each of the X chromosomes. This ratio can be skewed in
special cases, especially when the female is a carrier of an
X-chromosome disorder. It is thought that then, during
development, the cells in which the normal X chromo-
some remains active have a growth advantage over those
in which the abnormal X is selected. For skewing to be
used as a marker for carrier females, it is important to have
a comprehensive understanding of the variability of skew-
ing present in females with a normal phenotype. Other
groups have made an effort to establish a baseline mea-
surement of skewing, but good reproducibility of the as-
says has not always been obtained. Here, to achieve a high
level of replication and to evaluate the X-inactivation ra-
tio of 1,005 unaffected females, Amos-Landgraf et al. op-
timized their assay parameters. Overall, !8% of the studied
females had a skewed ratio of 180:20 or !20:80. This frame-
work allows the authors to propose that, if a ratio of 190:
10 or 195:5 is observed during screening, it is likely that
an X-chromosome defect is present.
Meiosis, Recombination, and the t(11;22), by
Ashley et al. (p. 524)
The translocation t(11;22)(q23;q11) is rare but recurrent
in germ cells. The rearrangement has been highly ob-
served during male meiosis, but it is unclear why these
two chromosomes are involved more often than other
chromosomes. The presence of lengths of palindromic AT-
rich sequence at the breakpoints on each chromosomehas
suggested that the repair and recombination following
a double-stranded break (DSB) of a DNA hairpin are in-
volved. But, because such DSB repair occurs throughout
the genome, this does not explain why chromosomes 11
and 22 speciﬁcally are recurrently involved. It is possible
that the bands involved in the rearrangement are each
recombination hotspots. In addition, previous work has
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demonstrated that the organization of the chromosomes
during meiosis is not random. Using FISH and immuno-
cytochemistry, Ashley et al. marked the two chromosomes
during meiosis, as well as a protein involved in recom-
bination. They discovered that the breakpoints on chro-
mosomes 11 and 22 are not hotspots but that their close
proximity to each other during meiosis is most likely a
key factor in their recurrent rearrangement with each other.
CEP290 Mutations Are a Frequent Cause of LCA,
by den Hollander et al. (p. 556)
Eight genes have been associated with the genetically het-
erogeneous Leber congenital amaurosis (LCA), a type of
recessive severe retinal dystrophy. den Hollander et al. de-
scribe a French Canadian LCA-affected family in which a
genomewide linkage scan suggested a new locus on12q21-
q22. The affected members of the families are found to be
homozygous for a splice-site mutation in the gene CEP290.
This mutation leads to the transcription of an abnormal
truncated transcript, along with residual levels of thewild-
type (WT) transcript. Screening of 76 unrelated patients
with LCA from various geographical locations identiﬁed
16 other individuals with mutations in CEP290, all of
whom had at least one copy of the splice-site mutation.
The predicted frequency of CEP290 mutations in LCA sug-
gests that dysfunctional CEP290 is one of the most com-
mon causes of the disease. Homozygous mutations in
CEP290 have also been linked to Joubert syndrome, a neu-
rological disorder often associated with renal disease and
retinal dystrophy. It is suggested that the low levels of WT
transcript produced by the splice-site variant are enough
to ensure proper neurological and kidney function in pa-
tients with LCA.
This Month on the Cover
The image on the cover is the chemical structure of phe-
nylalanine, the amino acid that cannot be metabolized
by patients with phenylketonuria (PKU). In 1934, Asbjo¨rn
Følling ﬁrst reported patients who had elevated levels of
phenylpyruvic acid in their urine and demonstrated an
associated mental retardation (Zeitschrift fu¨r Physiolog-
ische Chemie 227:169–176). It was later determined that
PKU was caused by a deﬁciency of the enzyme phenyl-
alanine hydroxylase, which is needed for proper phenyl-
alanine metabolism (Nature 306:151–155). It is the build-
up of the amino acid that causes the PKU phenotype and,
as ﬁrst demonstrated by Bickel et al. in 1953, treatment
with a diet low in phenylalanine can alleviate PKU symp-
toms (Lancet 2:812–813). Today, cases are detected through
newborn screening, and, by adhering to restricted diets,
affected individuals can develop normally. PKU is a land-
mark example of a genetic disease that can be effectively
diagnosed and treated.
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